Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Eledon Pharmaceuticals, Inc. Director's Dealing 2014

Sep 17, 2014

33900_dirs_2014-09-16_a2223701-f56f-4208-821a-ccd8dd71c7f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tokai Pharmaceuticals Inc (TKAI)
CIK: 0001404281
Period of Report: 2014-09-16

Reporting Person: Kessler David A. (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.11 2019-03-03 Common Stock (1910) Direct
Stock Option (right to buy) $0.63 2019-05-05 Common Stock (9910) Direct
Stock Option (right to buy) $1.37 2021-09-07 Common Stock (7306) Direct
Stock Option (right to buy) $1.58 2023-06-26 Common Stock (10373) Direct

Footnotes

F1: This option is fully vested.

F2: This option is fully vested.

F3: This option was granted on September 7, 2011. With respect to 635 shares underlying the option, 2.0833% of those shares vested on October 1, 2011 and an additional 2.0833% of those shares vest on the first day of each month thereafter through September 1, 2015. With respect to 794 shares underlying the option, 2.0833% of those shares vested on October 7, 2011 and
an additional 2.0833% of those shares vest on the first day of each month thereafter through September 1, 2015. With respect to 2,605 shares underlying the option, 8.3333% of those shares vested on January 27, 2012 and an additional 2.0833% of those shares vest on the first day of each month thereafter through September 1, 2015. With respect to 3,272 shares underlying the option, 20.8333% of those shares vested on July 12, 2012 and an additional 2.0833% of those shares vest on the first day of each month thereafter through September 1, 2015.

F4: This option was granted on June 26, 2013. With respect to 5,844 shares underlying the option, 2.0833% of those shares vested on July 1, 2013 and an additional 2.0833% of those shares vest on the first day of each month thereafter through June 1, 2017. With respect to 4,529 shares underlying the option, 8.333% of those shares vested on October 24, 2013 and an additional 2.0833% of those shares vest on the first day of each month thereafter through June 1, 2017.